Harvard University at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Harvard University brings 2 presentations to ESGCT 2026 in Hamburg. Its program covers gene editing and the translation of adeno-associated virus vectors toward clinical use.

OrganizationESGCT 2026 Attendance
Harvard University
Cambridge, Massachusetts
Universities & institutes
Private research university in Cambridge, Massachusetts.
Talk
Wed Oct 28
6:30pm–7:00pm
SESSION 6: Gene editing
SESSION 6: Gene editing
Gene and epigenome editing
Talk
Fri Oct 30
11:30am–1:00pm
SESSION 12a: AAVs/non integrative vectors III - Translation
SESSION 12a: AAVs/non integrative vectors III - Translation
Vectors and delivery (AAV, lentiviral, LNP)Clinical trials and translation

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Harvard University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction